These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27793530)

  • 1. [Primary lymphoma of the skull: Case report and literature review].
    Issara K; Yossi S; Caraivan I
    Cancer Radiother; 2016 Dec; 20(8):811-814. PubMed ID: 27793530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib.
    Tucker DL; Mihailescu L; Riordan R; Rule S
    Br J Haematol; 2017 Jul; 178(1):153-155. PubMed ID: 27172457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Primary non-Hodgkin's lymphoma of the skull in an 11-year-old girl. Follow-up and review of the literature].
    Daldrup HE; Reimer P; Wolf KJ; Peters PE
    Radiologe; 1996 Apr; 36(4):354-9. PubMed ID: 8677328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary non-Hodgkin lymphoma of the cranial vault.
    Naama O; Gazzaz M; Boucetta M; Elmoustarchid B
    Rev Neurol (Paris); 2017 Dec; 173(10):668-670. PubMed ID: 28629635
    [No Abstract]   [Full Text] [Related]  

  • 5. Parosteal osteosarcoma of the skull.
    Rodríguez-Arias CA; Lobato RD; Millán JM; Lagares A; de la Lama A; Alén JF
    Neurocirugia (Astur); 2001 Dec; 12(6):521-4. PubMed ID: 11787402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zanubrutinib: a novel BTK inhibitor in chronic lymphocytic leukemia and non-Hodgkin lymphoma.
    Tam CS
    Clin Adv Hematol Oncol; 2019 Jan; 17(1):32-34. PubMed ID: 30843894
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary diffuse large B-cell lymphomas of the temporoparietal dura mater and scalp without intervening skull bone invasion.
    Ochiai H; Kawano H; Miyaoka R; Kawano N; Shimao Y; Kawasaki K
    Neurol Med Chir (Tokyo); 2010; 50(7):595-8. PubMed ID: 20671390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of a novel, Bruton's tyrosine kinase inhibitor, ibrutinib.
    Lee CS; Rattu MA; Kim SS
    J Oncol Pharm Pract; 2016 Feb; 22(1):92-104. PubMed ID: 25425007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Bruton's tyrosine kinase-negative Hodgkin lymphoma during ibrutinib treatment of chronic lymphocytic leukaemia.
    Glavey S; Quinn J; McCloy M; Sargent J; McCartney Y; Catherwood M; Marafioti T; Leader M; Murphy P; Thornton P
    Eur J Haematol; 2017 Oct; 99(4):378-380. PubMed ID: 28561533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature.
    Molica S; Levato L; Mirabelli R
    Leuk Lymphoma; 2016; 57(3):735-7. PubMed ID: 26337717
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary Ewing's sarcoma of the skull: follow-up with bone scanning.
    Yildizhan A; Gezen F
    Neurosurg Rev; 1992; 15(3):225-9. PubMed ID: 1407612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Localized primary bone lymphoma: about four cases].
    Ben Salah H; Fourati N; Elloumi M; Boudawara T; Frikha M; Daoud J
    Cancer Radiother; 2014 Jan; 18(1):23-7. PubMed ID: 24316351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated fusarium infection after ibrutinib therapy in chronic lymphocytic leukaemia.
    Chan TS; Au-Yeung R; Chim CS; Wong SC; Kwong YL
    Ann Hematol; 2017 May; 96(5):871-872. PubMed ID: 28184982
    [No Abstract]   [Full Text] [Related]  

  • 14. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2004. A 40-year-old man with a large tumor of the skull.
    Richardson PG; Kassarjian A; Jing W
    N Engl J Med; 2004 Dec; 351(25):2637-45. PubMed ID: 15602025
    [No Abstract]   [Full Text] [Related]  

  • 15. Multifocal primary lymphoma of the cranial vault in a non-immunocompromised adolescent.
    Khalid M; Siddiqui MA; Qaseem SM; Ahmad M; Khalid S
    JBR-BTR; 2010; 93(6):296-8. PubMed ID: 21381526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What should standard frontline therapy be in older patients with chronic lymphocytic leukemia? Ibrutinib should be standard frontline therapy.
    Woyach JA
    Clin Adv Hematol Oncol; 2016 May; 14(5):330-3. PubMed ID: 27379693
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of ibrutinib in chronic lymphocytic leukemia.
    Damon LE
    Clin Adv Hematol Oncol; 2016 Mar; 14(3):154-6. PubMed ID: 27058026
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary Ewing's sarcoma of the calvarial skull.
    Roosen N; Lins E
    Neurochirurgia (Stuttg); 1991 Nov; 34(6):184-7. PubMed ID: 1775210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osseous metastases from a benign intraventricular meningioma. Case report.
    Couldwell WT; Fankhauser H; de Tribolet N
    Acta Neurochir (Wien); 1992; 117(3-4):195-9. PubMed ID: 1414521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary lymphoma of the cranial vault. Apropos of a case].
    Lonjon M; Hofman P; Thyss A; Paquis P; Roche JL
    Neurochirurgie; 1993; 39(1):50-3. PubMed ID: 8377886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.